| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.31▲ | 3.17▲ | 3.17▲ | 3.30▲ | 3.11▲ |
| MA10 | 3.19▲ | 3.17▲ | 3.20▲ | 3.12▲ | 3.75▼ |
| MA20 | 3.26▲ | 3.27▲ | 3.20▲ | 2.95▲ | 3.98▼ |
| MA50 | 3.17▲ | 2.97▲ | 2.85▲ | 3.85▼ | N/A |
| MA100 | 2.89▲ | 3.11▲ | 3.42▼ | 3.93▼ | N/A |
| MA200 | 3.44▼ | 3.98▼ | 4.06▼ | 5.44▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.012▲ | -0.015▼ | -0.010▼ | 0.134▲ | N/A |
| RSI | 59.564▲ | 61.759▲ | 61.467▲ | 53.303▲ | N/A |
| STOCH | 64.523 | 33.064 | 32.487 | 83.900▲ | 24.962 |
| WILL %R | -3.614▲ | -3.614▲ | -3.614▲ | 0.000▲ | -61.059 |
| CCI | 82.010 | 82.320 | 78.212 | 129.971▲ | -55.937 |
|
Tuesday, April 07, 2020 05:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating ...
|
|
Thursday, April 02, 2020 07:00 AM
This new capital pool will operate alongside separate Flagship funds totaling $1.08 billion raised in 2019 to support the financial needs of Flagship-originated companies after they spin out from ...
|
|
Monday, March 30, 2020 10:23 AM
Charah Solutions (NYSE:CHRA) +30%. Axcella Health (NASDAQ:AXLA) +29%. Piedmont Lithium (NASDAQ:PLL) +29%. Recro Pharma (NASDAQ:REPH) +25%. SCWorx (NASDAQ:WORX) +24%.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/04/20 | 3.42 | 3.50 | 3.34 | 3.50 | 55,422 |
| 03/04/20 | 2.80 | 3.43 | 2.80 | 3.38 | 35,000 |
| 02/04/20 | 2.89 | 3.3733 | 2.80 | 3.24 | 25,944 |
| 01/04/20 | 3.25 | 3.43 | 2.94 | 2.94 | 82,300 |
| 31/03/20 | 3.33 | 3.42 | 3.20 | 3.42 | 131,700 |
| 30/03/20 | 2.81 | 3.50 | 2.81 | 3.40 | 157,400 |
| 27/03/20 | 3.02 | 3.02 | 2.60 | 2.61 | 17,500 |
| 26/03/20 | 2.815 | 2.99 | 2.75 | 2.98 | 47,700 |
| 25/03/20 | 2.965 | 2.965 | 2.46 | 2.80 | 8,400 |
| 24/03/20 | 2.91 | 2.95 | 2.707 | 2.95 | 29,000 |
|
|
||||
|
|
||||
|
|